mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.7 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |